Should the presence of minimal residual disease (MRD) in morphologic complete remission alter post-remission strategy in AML? (Q37962783)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Should the presence of minimal residual disease (MRD) in morphologic complete remission alter post-remission strategy in AML?
scientific article

    Statements

    Should the presence of minimal residual disease (MRD) in morphologic complete remission alter post-remission strategy in AML? (English)
    9 November 2011
    509-514

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit